The report highlights the company's commitment to sustainable and responsible operations, focusing on four key areas: Access to Health, Employees, Environmental Sustainability and Ethics & Values. The report describes the company's efforts to expand access to innovative medicines and vaccines globally, its commitment to a diverse and inclusive workforce, its environmental stewardship program, and its commitment to ethical conduct. Some of the report highlights include: the company reached more than 550 million people with its medicines and vaccines in 2023, committed to a net-zero target for greenhouse gas emissions by 2045, achieved greater than 99 percent pay equity for female employees, and spent $3.6 billion with small and diverse Tier 1 and 2 suppliers globally.
